1. DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial. (6th November 2014) Authors: Humeau, Laurent; Trimble, Cornelia; Morrow, Matthew; Shen, Xuefei; Dallas, Michael; Weiner, David; Boyer, Jean; Yan, Jian; Kraynyak, Kimberly; Sylvester, Albert; Giffear, Mary; Marcozzi-Pierce, Kathy; Shah, Divya; Broderick, Kate; Khan, Amir; Lee, Jessica; Sardesai, Niranjan; Bargarazzi, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 571. Safety and Immunogenicity of INO-4800, a COVID-19 DNA Vaccine as a Primary Series and Booster. (4th December 2021) Authors: Tebas, Pablo; Agnes, Joseph; Giffear, Mary; Kraynyak, Kimberly A; Blackwood, Elliott; Amante, Dinah; Reuschel, Emma; Liu, Neiman; Purwar, Mansi; Christensen-Quick, Aaron; Andrade, Viviane M; Carter, Julie; Garufi, Gabriella; Diehl, Malissa; Sylvester, Albert; Morrow, Matthew P; Pezzoli, Patrick P... Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 571. Safety and Immunogenicity of INO-4800, a COVID-19 DNA Vaccine as a Primary Series and Booster. (4th December 2021) Authors: Tebas, Pablo; Agnes, Joseph; Giffear, Mary; Kraynyak, Kimberly A; Blackwood, Elliott; Amante, Dinah; Reuschel, Emma; Liu, Neiman; Purwar, Mansi; Christensen-Quick, Aaron; Andrade, Viviane M; Carter, Julie; Garufi, Gabriella; Diehl, Malissa; Sylvester, Albert; Morrow, Matthew P; Pezzoli, Patrick P... Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population. Issue 6 (2nd June 2020) Authors: Hollenberg, Rebecca K.; Krieger, Diane R.; Samuels, Robert; Kraynyak, Kim; Sylvester, Albert; Morrow, Matthew; Boyer, Jean; Dallas, Michael; Bhuyan, Prakash K. Journal: Human vaccines & immunotherapeutics Issue: Volume 16:Issue 6(2020) Page Start: 1404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial. (25th January 2022) Authors: Kraynyak, Kimberly A; Blackwood, Elliott; Agnes, Joseph; Tebas, Pablo; Giffear, Mary; Amante, Dinah; Reuschel, Emma L; Purwar, Mansi; Christensen-Quick, Aaron; Liu, Neiman; Andrade, Viviane M; Diehl, Malissa C; Wani, Snehal; Lupicka, Martyna; Sylvester, Albert; Morrow, Matthew P; Pezzoli, Patrick... Journal: Journal of infectious diseases Issue: Volume 225:Number 11(2022) Page Start: 1923 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL. Issue 5 (4th May 2021) Authors: Bhuyan, Prakash K.; Dallas, Michael; Kraynyak, Kim; Herring, Timothy; Morrow, Matthew; Boyer, Jean; Duff, Susan; Kim, Joseph; Weiner, David B. Journal: Human vaccines & immunotherapeutics Issue: Volume 17:Issue 5(2021) Page Start: 1288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial. Issue 10008 (21st November 2015) Authors: Trimble, Cornelia L; Morrow, Matthew P; Kraynyak, Kimberly A; Shen, Xuefei; Dallas, Michael; Yan, Jian; Edwards, Lance; Parker, R Lamar; Denny, Lynette; Giffear, Mary; Brown, Ami Shah; Marcozzi-Pierce, Kathleen; Shah, Divya; Slager, Anna M; Sylvester, Albert J; Khan, Amir; Broderick, Kate E; Juba... Journal: Lancet Issue: Volume 386:Issue 10008(2015) Page Start: 2078 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. Issue 45 (29th October 2018) Authors: Greenberg, David; Hoover, Patricia A.; Vesikari, Timo; Peltier, Christopher; Hurley, David C.; McFetridge, Richard D.; Dallas, Michael; Hartzel, Jonathan; Marchese, Rocio D.; Coller, Beth-Ann G.; Stek, Jon E.; Abeygunawardana, Chitrananda; Winters, Michael A.; MacNair, John E.; Pujar, Narahari S.... Journal: Vaccine Issue: Volume 36:Issue 45(2018) Page Start: 6883 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults. Issue 24 (4th June 2015) Authors: McFetridge, Richard; Meulen, Ajoke Sobanjo-ter; Folkerth, Steven D.; Hoekstra, John A.; Dallas, Michael; Hoover, Patricia A.; Marchese, Rocio D.; Zacholski, Donna M.; Watson, Wendy J.; Stek, Jon E.; Hartzel, Jonathan S.; Musey, Luwy K. Journal: Vaccine Issue: Volume 33:Issue 24(2015) Page Start: 2793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗